In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sanofi-Aventis Ambien CR Launch Gets Up And Going

This article was originally published in The Pink Sheet Daily

Executive Summary

Sleep aid introduction is being promoted with 3,500 sales reps, DTC ads breaking mid-November.

You may also be interested in...



Sanofi Will Maintain “Massive” Investment Behind Ambien CR

Company will continue to invest in sales reps, DTC ads for sleep aid in line with competitors' spending.

Sanofi Will Maintain “Massive” Investment Behind Ambien CR

Company will continue to invest in sales reps, DTC ads for sleep aid in line with competitors' spending.

Ambien Nightmare? Sanofi Marketing Targeted In Civil Class Action

A class action suit alleges Sanofi-Aventis failed to adequately warn patients of the risk of sleep walking and sleep eating associated with the insomnia product.

Related Content

Topics

UsernamePublicRestriction

Register

PS061357

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel